Myasthenia Gravis Therapies Market Report

Global and Region Myasthenia Gravis Therapies Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 01, 2022
  • PAGES：145
  • REPORT CODE：GMM975913
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Myasthenia gravis is a chronic autoimmune neuromuscular disease that causes weakness in the skeletal muscles, which are responsible for breathing and moving parts of the body, including the arms and legs.

    The report details the trend, potential and market size of Myasthenia Gravis Therapies market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Myasthenia Gravis Therapiesmarket, defines the market attractiveness level of Myasthenia Gravis Therapies market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Myasthenia Gravis Therapies industry, describes the types of Myasthenia Gravis Therapies market, the applications of major players and the market size, and deeply analyzes the current situation of the global Myasthenia Gravis Therapies market and the development prospects and opportunities of Myasthenia Gravis Therapies industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Myasthenia Gravis Therapies market in Chapter 13.

    By Player:

    • FHoffmann-La Roche AG

    • Bausch Health Companies Inc

    • Grifols SA

    • Pfizer, Inc

    • Novartis

    • GlaxoSmithKline Plc

    • Shire plc

    • Alexion Pharmaceutical Inc

    • Avadel Pharmaceuticals, Plc

    • AbbVie Inc

    By Type:

    • Ocular Myasthenia Gravis

    • Congenital Myasthenia Gravis

    • Generalized Myasthenia Gravis

    • Transient Myasthenia Gravis

    • Others

    By End-User:

    • Hospitals and Clinics

    • Diagnostic Centers

    • Academic and Research Organizations

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Myasthenia Gravis Therapies Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Myasthenia Gravis Therapies Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Myasthenia Gravis Therapies Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Myasthenia Gravis Therapies Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Myasthenia Gravis Therapies Market Analysis and Outlook to 2022

    • 7.1 Global Myasthenia Gravis Therapies Consumption (2017-2022)

    • 7.2 United States Myasthenia Gravis Therapies Consumption (2017-2022)

    • 7.3 Europe Myasthenia Gravis Therapies Consumption (2017-2022)

    • 7.4 China Myasthenia Gravis Therapies Consumption (2017-2022)

    • 7.5 Japan Myasthenia Gravis Therapies Consumption (2017-2022)

    • 7.6 India Myasthenia Gravis Therapies Consumption (2017-2022)

    • 7.7 South Korea Myasthenia Gravis Therapies Consumption (2017-2022)

    8 Region and Country-wise Myasthenia Gravis Therapies Market Analysis and Outlook to 2028

    • 8.1 Global Myasthenia Gravis Therapies Consumption Forecast (2022-2028)

    • 8.2 United States Myasthenia Gravis Therapies Consumption Forecast (2022-2028)

    • 8.3 Europe Myasthenia Gravis Therapies Consumption Forecast (2022-2028)

    • 8.4 China Myasthenia Gravis Therapies Consumption Forecast (2022-2028)

    • 8.5 Japan Myasthenia Gravis Therapies Consumption Forecast (2022-2028)

    • 8.6 India Myasthenia Gravis Therapies Consumption Forecast (2022-2028)

    • 8.7 South Korea Myasthenia Gravis Therapies Consumption Forecast (2022-2028)

    9 Global Myasthenia Gravis Therapies Market Outlook by Types and Applications to 2022

    • 9.1 Global Myasthenia Gravis Therapies Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Ocular Myasthenia Gravis Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Congenital Myasthenia Gravis Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Generalized Myasthenia Gravis Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Transient Myasthenia Gravis Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global Myasthenia Gravis Therapies Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospitals and Clinics Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Diagnostic Centers Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Academic and Research Organizations Consumption and Growth Rate (2017-2022)

    10 Global Myasthenia Gravis Therapies Market Outlook by Types and Applications to 2028

    • 10.1 Global Myasthenia Gravis Therapies Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Ocular Myasthenia Gravis Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Congenital Myasthenia Gravis Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Generalized Myasthenia Gravis Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Transient Myasthenia Gravis Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.5 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Myasthenia Gravis Therapies Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospitals and Clinics Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Diagnostic Centers Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Academic and Research Organizations Consumption Forecast and Growth Rate (2022-2028)

    11 Global Myasthenia Gravis Therapies Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Myasthenia Gravis Therapies Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Myasthenia Gravis Therapies Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Myasthenia Gravis Therapies Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Myasthenia Gravis Therapies Market Competitive Analysis

    • 14.1 FHoffmann-La Roche AG

      • 14.1.1 FHoffmann-La Roche AG Company Details

      • 14.1.2 FHoffmann-La Roche AG Myasthenia Gravis Therapies Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 FHoffmann-La Roche AG Myasthenia Gravis Therapies Product and Service

    • 14.2 Bausch Health Companies Inc

      • 14.2.1 Bausch Health Companies Inc Company Details

      • 14.2.2 Bausch Health Companies Inc Myasthenia Gravis Therapies Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Bausch Health Companies Inc Myasthenia Gravis Therapies Product and Service

    • 14.3 Grifols SA

      • 14.3.1 Grifols SA Company Details

      • 14.3.2 Grifols SA Myasthenia Gravis Therapies Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Grifols SA Myasthenia Gravis Therapies Product and Service

    • 14.4 Pfizer, Inc

      • 14.4.1 Pfizer, Inc Company Details

      • 14.4.2 Pfizer, Inc Myasthenia Gravis Therapies Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Pfizer, Inc Myasthenia Gravis Therapies Product and Service

    • 14.5 Novartis

      • 14.5.1 Novartis Company Details

      • 14.5.2 Novartis Myasthenia Gravis Therapies Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Novartis Myasthenia Gravis Therapies Product and Service

    • 14.6 GlaxoSmithKline Plc

      • 14.6.1 GlaxoSmithKline Plc Company Details

      • 14.6.2 GlaxoSmithKline Plc Myasthenia Gravis Therapies Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 GlaxoSmithKline Plc Myasthenia Gravis Therapies Product and Service

    • 14.7 Shire plc

      • 14.7.1 Shire plc Company Details

      • 14.7.2 Shire plc Myasthenia Gravis Therapies Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Shire plc Myasthenia Gravis Therapies Product and Service

    • 14.8 Alexion Pharmaceutical Inc

      • 14.8.1 Alexion Pharmaceutical Inc Company Details

      • 14.8.2 Alexion Pharmaceutical Inc Myasthenia Gravis Therapies Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Alexion Pharmaceutical Inc Myasthenia Gravis Therapies Product and Service

    • 14.9 Avadel Pharmaceuticals, Plc

      • 14.9.1 Avadel Pharmaceuticals, Plc Company Details

      • 14.9.2 Avadel Pharmaceuticals, Plc Myasthenia Gravis Therapies Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Avadel Pharmaceuticals, Plc Myasthenia Gravis Therapies Product and Service

    • 14.10 AbbVie Inc

      • 14.10.1 AbbVie Inc Company Details

      • 14.10.2 AbbVie Inc Myasthenia Gravis Therapies Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 AbbVie Inc Myasthenia Gravis Therapies Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Myasthenia Gravis Therapies

    • Figure Myasthenia Gravis Therapies Picture

    • Table Global Myasthenia Gravis Therapies Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Myasthenia Gravis Therapies Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Myasthenia Gravis Therapies Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Myasthenia Gravis Therapies Consumption by Country (2017-2022)

    • Figure United States Myasthenia Gravis Therapies Consumption and Growth Rate (2017-2022)

    • Table Europe Myasthenia Gravis Therapies Consumption and Growth Rate (2017-2022)

    • Figure China Myasthenia Gravis Therapies Consumption and Growth Rate (2017-2022)

    • Figure Japan Myasthenia Gravis Therapies Consumption and Growth Rate (2017-2022)

    • Figure India Myasthenia Gravis Therapies Consumption and Growth Rate (2017-2022)

    • Figure South Korea Myasthenia Gravis Therapies Consumption and Growth Rate (2017-2022)

    • Figure Global Myasthenia Gravis Therapies Consumption Forecast by Country (2022-2028)

    • Figure United States Myasthenia Gravis Therapies Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Myasthenia Gravis Therapies Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Myasthenia Gravis Therapies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Myasthenia Gravis Therapies Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Myasthenia Gravis Therapies Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Myasthenia Gravis Therapies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Ocular Myasthenia Gravis Consumption and Growth Rate (2017-2022)

    • Figure Global Congenital Myasthenia Gravis Consumption and Growth Rate (2017-2022)

    • Figure Global Generalized Myasthenia Gravis Consumption and Growth Rate (2017-2022)

    • Figure Global Transient Myasthenia Gravis Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Hospitals and Clinics Consumption and Growth Rate (2017-2022)

    • Figure Global Diagnostic Centers Consumption and Growth Rate (2017-2022)

    • Figure Global Academic and Research Organizations Consumption and Growth Rate (2017-2022)

    • Figure Global Ocular Myasthenia Gravis Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Congenital Myasthenia Gravis Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Generalized Myasthenia Gravis Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Transient Myasthenia Gravis Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospitals and Clinics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Diagnostic Centers Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Academic and Research Organizations Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Myasthenia Gravis Therapies Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Myasthenia Gravis Therapies Export by Region (Top 5 Countries) (2017-2028)

    • Table FHoffmann-La Roche AG (Foundation Year, Company Profile and etc.)

    • Table FHoffmann-La Roche AG Myasthenia Gravis Therapies Sales, Price, Value and Gross Profit (2017-2022)

    • Table FHoffmann-La Roche AG Myasthenia Gravis Therapies Product and Service

    • Table Bausch Health Companies Inc (Foundation Year, Company Profile and etc.)

    • Table Bausch Health Companies Inc Myasthenia Gravis Therapies Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bausch Health Companies Inc Myasthenia Gravis Therapies Product and Service

    • Table Grifols SA (Foundation Year, Company Profile and etc.)

    • Table Grifols SA Myasthenia Gravis Therapies Sales, Price, Value and Gross Profit (2017-2022)

    • Table Grifols SA Myasthenia Gravis Therapies Product and Service

    • Table Pfizer, Inc (Foundation Year, Company Profile and etc.)

    • Table Pfizer, Inc Myasthenia Gravis Therapies Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer, Inc Myasthenia Gravis Therapies Product and Service

    • Table Novartis (Foundation Year, Company Profile and etc.)

    • Table Novartis Myasthenia Gravis Therapies Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis Myasthenia Gravis Therapies Product and Service

    • Table GlaxoSmithKline Plc (Foundation Year, Company Profile and etc.)

    • Table GlaxoSmithKline Plc Myasthenia Gravis Therapies Sales, Price, Value and Gross Profit (2017-2022)

    • Table GlaxoSmithKline Plc Myasthenia Gravis Therapies Product and Service

    • Table Shire plc (Foundation Year, Company Profile and etc.)

    • Table Shire plc Myasthenia Gravis Therapies Sales, Price, Value and Gross Profit (2017-2022)

    • Table Shire plc Myasthenia Gravis Therapies Product and Service

    • Table Alexion Pharmaceutical Inc (Foundation Year, Company Profile and etc.)

    • Table Alexion Pharmaceutical Inc Myasthenia Gravis Therapies Sales, Price, Value and Gross Profit (2017-2022)

    • Table Alexion Pharmaceutical Inc Myasthenia Gravis Therapies Product and Service

    • Table Avadel Pharmaceuticals, Plc (Foundation Year, Company Profile and etc.)

    • Table Avadel Pharmaceuticals, Plc Myasthenia Gravis Therapies Sales, Price, Value and Gross Profit (2017-2022)

    • Table Avadel Pharmaceuticals, Plc Myasthenia Gravis Therapies Product and Service

    • Table AbbVie Inc (Foundation Year, Company Profile and etc.)

    • Table AbbVie Inc Myasthenia Gravis Therapies Sales, Price, Value and Gross Profit (2017-2022)

    • Table AbbVie Inc Myasthenia Gravis Therapies Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US